Tegafur Gimeracil Oteracil Potassium Capsules

DRUG2 trials

Sponsors

Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University

Conditions

Head and Neck Squamous Cell Carcinoma

Phase 2

A Study of Apatinib Plus Tegafur Gimeracil Oteracil in Recurrent/Metastatic Head and Neck Cancers

Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong UniversityHead and Neck Squamous Cell Carcinoma

Start: 2016-12-23End: 2019-05-01Target: 38Updated: 2018-10-09

A Study of Apatinib and Tegafur Gimeracil Oteracil in Locally Advanced Squamous Cell Carcinoma of the Head and Neck

CompletedNCT03267121

Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong UniversityHead and Neck Squamous Cell Carcinoma

Start: 2017-10-01End: 2020-11-01Updated: 2023-10-17

Related Papers

Efficacy and feasibility of Apatinib and S-1 as a novel oral induction therapy in locally advanced head and neck squamous cell carcinoma: an exploratory phase 2 open-label, single-arm trial

Frontiers in Oncology2023-05-121 citations